A prospective, observational, multicenter study comparing Tenecteplase facilitated PCI versus primary PCI in Indian patients with STEMI - STEPPAMI

STEMI India Charitable Trust0 个研究点目标入组 200 人开始时间: 待定最近更新: 2021年11月24日

试验速览

暂无简介。

•All patients included in the study should satisfy the following criteria.
•1.Adults 18 to 75 years of age complaining of chest pain, discomfort and/or indications of STEMI requiring either primary PCI or tenecteplase facilitated PCI will be included in the study.
•2.Patients presenting with the onset of symptoms within 12 hours.
•3.ECG including right ventricular leads (V4R) indicative of an acute STEMI (ST elevation will be measured from the J point scale; 1 mm per 0.1 mV greater than or equal to 2 mm ST elevation across 2 contiguous precordial leads (V1-V6) or leads I and aVL for a minimum combined total of greater than or equal to 4 mm ST elevation)
•Greater than or equal to 3mm ST elevation in 2 contiguous inferior leads (II, III, aVF) for a minimum combined total of greater than or equal to 6 mm ST elevation.
•4.Subjects / LAR or impartial witness (if applicable) must be able to understand and provide their consent in the informed consent form.

•Patients meeting any of the following criteria will not be enrolled into the study.
•1.Previous enrollment in this study or treatment with the investigational drug or participating in any other study in the past 30 days
•2.Patients who are unwilling to participate in the study or sign the informed consent

发起方

STEMI India Charitable Trust